Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
C., Schweder, M
Abbreviations MASLD : Metabolic dysfunction-associated steatotic liver disease MASH : Metabolic dysfunction-associated steatohepatitis T2DM : Type 2 diabetes mellitus GLP-1 RAs : Glucagon-like peptide-1 receptor agonists GIP : Glucose-dependent insulinotropic polypeptide GCG : Glucagon AACE : American Association of Clinical Endocrinology AASLD : American Association for the Study of the Liver Diseases F2 : Fibrosis grade 2 ABCD : Adiposity-based chronic diseases EASO : European Association for the Study of Obesity VAT : Visceral adipose tissue FFA : Free fatty acids HSC : Hepatic stellate cells FDA : Food and drug administration F3 : Fibrosis grade 3 AST : Aspartate aminotransferase ALT : Alanine aminotransferase GGT : Gamma-glutamyl transferase NAFLD : Non-alcoholic fatty liver-disease LFC : Liver fat content MRI-PDFF : Magnetic resonance imaging derived proton density fat fraction ELF : Enhanced liver fibrosis FIB-4 : Fibrosis-4 index F1 : Fibrosis grade 1 NAS : NAFLD activity score AE : Adverse event SAE : Serious adverse event EMA : European Medicine Agency FGF21 : Fibroblast growth factor 21 MetALD : Metabolic dysfunction and alcohol-related liver disease References Le MH, Le DM, Baez TC, Wu Y, Ito T, Lee EY, Lee K, Stave CD, Henry L, Barnett SD, Cheung R, Nguyen MH
Swissmedic expressly warns against its use in Switzerland
This clean profile makes it a preferred reference peptide in GH-axis studies
Q: Is long-term use safe
US$ 26.22
US$ 21.15
US$ 28.39
US$ 29.27
US$ 24.95
US$ 29.74
US$ 25.45
US$ 29.86
US$ 27.73
US$ 26.80
US$ 25.42
US$ 27.39
US$ 26.37
US$ 20.37
